← Back

Dalian Bio-Chem Co Ltd

Dalian BIO-CHEM Company Limited engages in the research and development, production, and sale of industrial fungicides in China and internationally. It offers various isothiazolinone fungicides, including CMIT/MIT, MIT, OIT, DCOIT, and BIT series products; and OEM/ODM services. The company was founded in 2003 and is based in Dalian, China.

Price · split & dividend adjusted
News & notes moving 603360.CG
603360.CG

Bai'ao Chemical's 2026 interim report shows net profit down 34.76%

Bai'ao Chemical released its 2026 interim report. Total operating revenue was 580 million yuan, down 26.60% year on year. Net profit attributable to the parent company was 64.4191 million yuan, down 34.76% from the same period last year. Net cash flow from operating activities was negative 71.7532 million yuan, a decrease of 66.0758 million yuan year on year. The company's asset-liability ratio was 47.04%, up 7.99 percentage points from the same period last year. Gross margin was 32.61%, down 1.48 percentage points year on year. Return on equity was 4.59%, down 1.44 percentage points year on year. Diluted earnings per share were 0.09 yuan, down 35.71% year on year.
Jiemian·1dRead more ▾
603360.CG

Tianzhihang Plans Major Asset Restructuring, Resumes Trading Thursday; Yunzhong Technology MLCC Orders Surge but Still in the Red

Tianzhihang is planning to acquire a 62% stake in Shanghai Minimally Invasive Orthopedics Medical Technology Co., Ltd. through a share issuance, along with raising supporting funds, which is expected to constitute a major asset restructuring. Trading in the company's shares will resume on July 30. Jianghuai Micro is set to acquire a 15.50% stake in its holding subsidiary, Jiangyin Jianghuai Fuxin Electronic Materials Co., Ltd., for 1.5024 million yuan, after which it will hold 100% equity. Zhongke Tongda shareholder Wuhan Optics Valley Growth Venture Capital Fund plans to reduce its holdings by no more than 3.4911 million shares, representing no more than 3.00% of total share capital. Hunan Haili's controlling shareholder, Haili Group, increased its holdings by 1.6177 million shares, raising its stake from 23.71% to 24.00%, with the equity change hitting a 1% integer multiple. GigaDevice's actual controller, Zhu Yiming, plans to increase his holdings in the company from December 13, 2026, to July 29, 2027, with the increase amounting to no less than 1 billion yuan. Western Mining reported a first-half net profit attributable to the parent of 4.169 billion yuan, up 123% year-on-year; Chengtun Mining reported a first-half net profit attributable to the parent of 1.804 billion yuan, up 71.37% year-on-year; Hongfa Technology reported a first-half net profit attributable to the parent of 1.156 billion yuan, up 19.89% year-on-year. AsiaInfo Security's holding subsidiary, AsiaInfo China, had bank account funds of 151 million yuan frozen, accounting for 8.71% of the company's latest audited net assets. Bio-chem Technology shareholder Guangyao Zhixin had 37.59 million company shares frozen. Century Huatong shareholders Yaoquru, Yiqusheng, Jiyufan, and Huatong Holdings were ordered by the Zhejiang Securities Regulatory Bureau to take corrective measures and had the matter recorded in their integrity files for failing to fulfill 2020 performance commitment compensation obligations. In response to a Shanghai Stock Exchange annual report inquiry, Yunzhong Technology disclosed that its MLCC business had on-hand orders at the end of June 2026 that surged 831.50% compared to the end of December 2025, but the business remains in a loss-making state. In 2025, its operating revenue was 60.1524 million yuan, accounting for 10.68% of the company's total operating revenue, with products mainly used in the consumer electronics sector and not yet applied in AI computing servers.
每日经济新闻·29dRead more ▾
603360.CG

Bai Ao Chemical Director and General Manager Liu Hongjun Increases Stake by 9,900 Shares

Bai Ao Chemical announced that on July 8, 2026, Director and General Manager Liu Hongjun increased his stake in the company by 9,900 shares through the Shanghai Stock Exchange's centralized competitive trading system, using his own funds, with a total purchase amount of 144,441 yuan. The company stated that this increase does not trigger a change in equity, will not cause the company's share distribution to fail to meet listing conditions, and will not lead to a change in the controlling shareholder or actual controller.
Jiemian·50dRead more ▾